Science Explorer Back to mapMap
Discussion
Company · Burlingame · United States

Collaborative Drug Discovery (United States)

collaborativedrug.comROR OpenAlex
World rank, all time
#27,626
of 34,923
Rank in United States
#5,781
of 7,310
Research works
158
▲ 4% vs 2018-21
Citations
4.4k
27.9 per fractional work
Top-10% rate
6.9%
all institutions 10.0%
vs its own fields
1.00×
1.00× is exactly expected
Open access
33%
world 40%
International
17%
world 18%
Collaborative Drug Discovery (United States)

Which fields of science does Collaborative Drug Discovery (United States) work in?

In 2022-now, 39% of research at Collaborative Drug Discovery (United States) is in Health Sciences, 31% in Physical Sciences. Its largest fields are Medicine (35%), Computer Science (15%), Engineering (10%). It does 1.5× the world's share of Health Sciences.

Health Sciences: 15 fractional works · 38.9% of its workMedicine: 13 fractional works · 35.2% of its workOncology: 2 fractional works · 6.1% of its workEndocrinology, Diabetes and Metabolism: 2 fractional works · 5.3% of its workPulmonary and Respiratory Medicine: 1 fractional works · 3.9% of its workSurgery: 1 fractional works · 3.0% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 2.6% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 2.5% of its workPsychiatry and Mental health: 1 fractional works · 2.0% of its workEpidemiology: 1 fractional works · 1.7% of its workRheumatology: 0 fractional works · 1.3% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 1.3% of its workPharmacology: 0 fractional works · 1.2% of its workHealth Informatics: 0 fractional works · 1.0% of its workNeurology: 0 fractional works · 1.0% of its workPathology and Forensic Medicine: 0 fractional works · 0.7% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.5% of its workAnesthesiology and Pain Medicine: 0 fractional works · 0.3% of its workGenetics: 0 fractional works · 0.3% of its workObstetrics and Gynecology: 0 fractional works · 0.3% of its workPhysiology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workHealth Professions: 1 fractional works · 3.7% of its workEmergency Medical Services: 1 fractional works · 2.6% of its workGeneral Health Professions: 0 fractional works · 0.8% of its workSmaller subfields together: 0 fractional works · 0.3% of its workPhysical Sciences: 12 fractional works · 31.3% of its workComputer Science: 6 fractional works · 14.7% of its workHuman-Computer Interaction: 2 fractional works · 4.4% of its workArtificial Intelligence: 1 fractional works · 2.5% of its workComputer Vision and Pattern Recognition: 1 fractional works · 2.2% of its workComputer Networks and Communications: 1 fractional works · 1.8% of its workInformation Systems: 0 fractional works · 1.0% of its workComputational Theory and Mathematics: 0 fractional works · 1.0% of its workComputer Science Applications: 0 fractional works · 0.9% of its workComputer Graphics and Computer-Aided Design: 0 fractional works · 0.8% of its workSmaller subfields together: 0 fractional works · 0.2% of its workEngineering: 4 fractional works · 10.3% of its workBiomedical Engineering: 1 fractional works · 3.8% of its workControl and Systems Engineering: 1 fractional works · 2.4% of its workElectrical and Electronic Engineering: 0 fractional works · 0.9% of its workAutomotive Engineering: 0 fractional works · 0.9% of its workSafety, Risk, Reliability and Quality: 0 fractional works · 0.9% of its workMechanical Engineering: 0 fractional works · 0.6% of its workComputational Mechanics: 0 fractional works · 0.5% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 0.3% of its workEnvironmental Science: 1 fractional works · 2.6% of its workGlobal and Planetary Change: 0 fractional works · 0.9% of its workManagement, Monitoring, Policy and Law: 0 fractional works · 0.9% of its workEcology: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.4% of its workPhysics and Astronomy: 1 fractional works · 1.6% of its workAtomic and Molecular Physics, and Optics: 0 fractional works · 0.9% of its workInstrumentation: 0 fractional works · 0.3% of its workNuclear and High Energy Physics: 0 fractional works · 0.2% of its workRadiation: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.0% of its workMaterials Science: 0 fractional works · 0.9% of its workMaterials Chemistry: 0 fractional works · 0.6% of its workCeramics and Composites: 0 fractional works · 0.3% of its workEnergy: 0 fractional works · 0.9% of its workRenewable Energy, Sustainability and the Environment: 0 fractional works · 0.9% of its workMathematics: 0 fractional works · 0.3% of its workStatistics and Probability: 0 fractional works · 0.3% of its workChemistry: 0 fractional works · 0.1% of its workSocial Sciences: 7 fractional works · 17.2% of its workPsychology: 3 fractional works · 6.9% of its workGeneral Psychology: 1 fractional works · 2.6% of its workApplied Psychology: 1 fractional works · 1.6% of its workExperimental and Cognitive Psychology: 0 fractional works · 1.2% of its workClinical Psychology: 0 fractional works · 0.7% of its workSocial Psychology: 0 fractional works · 0.7% of its workSocial Sciences: 1 fractional works · 3.8% of its workPolitical Science and International Relations: 1 fractional works · 2.6% of its workSociology and Political Science: 0 fractional works · 1.1% of its workSmaller subfields together: 0 fractional works · 0.1% of its workBusiness, Management and Accounting: 1 fractional works · 2.6% of its workBusiness and International Management: 0 fractional works · 0.9% of its workManagement Information Systems: 0 fractional works · 0.9% of its workMarketing: 0 fractional works · 0.9% of its workSmaller subfields together: 0 fractional works · 0.0% of its workEconomics, Econometrics and Finance: 1 fractional works · 2.0% of its workEconomics and Econometrics: 1 fractional works · 2.0% of its workDecision Sciences: 0 fractional works · 0.9% of its workManagement Science and Operations Research: 0 fractional works · 0.9% of its workSmaller subfields together: 0 fractional works · 0.1% of its workArts and Humanities: 0 fractional works · 0.9% of its workPhilosophy: 0 fractional works · 0.9% of its workLife Sciences: 5 fractional works · 12.6% of its workBiochemistry, Genetics and Molecular Biology: 3 fractional works · 7.6% of its workMolecular Biology: 2 fractional works · 6.1% of its workCancer Research: 0 fractional works · 1.1% of its workBiophysics: 0 fractional works · 0.3% of its workPhysiology: 0 fractional works · 0.2% of its workNeuroscience: 1 fractional works · 2.5% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.9% of its workNeurology: 0 fractional works · 0.7% of its workCognitive Neuroscience: 0 fractional works · 0.5% of its workBehavioral Neuroscience: 0 fractional works · 0.4% of its workImmunology and Microbiology: 1 fractional works · 2.1% of its workImmunology: 1 fractional works · 2.0% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.4% of its workPharmacology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workALL ITS WORKCollaborativeDrug Discovery…38fractional works, 2022-now
Life Sciences13%Physical Sciences31%Health Sciences39%Social Sciences17%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 20 fields, with their numbers
    1. Medicine1335.2%
    2. Health Professions13.7%
    1. Computer Science614.7%
    2. Engineering410.3%
    3. Environmental Science12.6%
    4. Physics and Astronomy11.6%
    5. Materials Science00.9%
    6. Energy00.9%
    7. Mathematics00.3%
    8. Chemistry00.1%
    1. Psychology36.9%
    2. Social Sciences13.8%
    3. Business, Management and Accounting12.6%
    4. Economics, Econometrics and Finance12.0%
    5. Decision Sciences00.9%
    6. Arts and Humanities00.9%
    1. Biochemistry, Genetics and Molecular Biology37.6%
    2. Neuroscience12.5%
    3. Immunology and Microbiology12.1%
    4. Pharmacology, Toxicology and Pharmaceutics00.4%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.43× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 2.07× its world share, 1 worksImmunology and Micro…Neuroscience: 1.55× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 1.12× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.05× its world share, 0 worksChemistryComputer Science: 1.88× its world share, 6 worksComputer ScienceEnergy: 0.96× its world share, 0 worksEnergyEngineering: 0.69× its world share, 4 worksEngineeringEnvironmental Science: 0.51× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.27× its world share, 0 worksMaterials ScienceMathematics: 0.25× its world share, 0 worksMathematicsPhysics and Astronomy: 0.72× its world share, 1 worksPhysics and AstronomyHealth Professions: 1.40× its world share, 1 worksHealth ProfessionsMedicine: 1.83× its world share, 13 worksMedicineArts and Humanities: 0.30× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.82× its world share, 1 worksBusiness, Management…Decision Sciences: 0.97× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.94× its world share, 1 worksEconomics, Econometr…Psychology: 2.27× its world share, 3 worksPsychologySocial Sciences: 0.30× its world share, 2 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Psychology, 2.3×. Every wedge is a field page.

All 20 fields, with their numbers
  1. Psychology2.27×3 works
  2. Immunology and Microbiology2.07×1 works
  3. Computer Science1.88×6 works
  4. Medicine1.83×13 works
  5. Neuroscience1.55×1 works
  6. Biochemistry, Genetics and Molecular Biology1.43×3 works
  7. Health Professions1.40×1 works
  8. Pharmacology, Toxicology and Pharmaceutics1.12×0 works
  9. Decision Sciences0.97×0 works
  10. Energy0.96×0 works
  11. Economics, Econometrics and Finance0.94×1 works
  12. Business, Management and Accounting0.82×1 works
  13. Physics and Astronomy0.72×1 works
  14. Engineering0.69×4 works
  15. Environmental Science0.51×1 works
  16. Arts and Humanities0.30×0 works
  17. Social Sciences0.30×2 works
  18. Materials Science0.27×0 works
  19. Mathematics0.25×0 works
  20. Chemistry0.05×0 works

Who are the top researchers at Collaborative Drug Discovery (United States)?

Ranked on the quality score, Barry A. Bunin lead among researchers whose main affiliation is Collaborative Drug Discovery (United States).

  1. 1 Barry A. Bunin United States · #1,156,776 worldwide 1.8k citations · 54 works
All ranked researchers at Collaborative Drug Discovery (United States)

What are the most cited papers from Collaborative Drug Discovery (United States)?

The most cited paper from Collaborative Drug Discovery (United States) is "The cancer-immunity cycle: Indication, genotype, and immunotype" (Ira Mellman, Daniel S. Chen, Thomas B. Powles et al., 2023), with 958 citations. Next come "Knowledge and Perception of Facial Candling for Allergic Rhinitis among University Staff and Students" (303) and "In silico repositioning of approved drugs for rare and neglected diseases" (296).

Most cited papers
#PaperReleasedCitations
1 The cancer-immunity cycle: Indication, genotype, and immunotype Ira Mellman, Daniel S. Chen, Thomas B. Powles et al. · Immunity Open access Oct 2023 958
2 Knowledge and Perception of Facial Candling for Allergic Rhinitis among University Staff and Students Nurul Khaleeda Athiraah Hamdan, Qi Ying Lean, Chin Fen Neoh et al. · Evidence-based Complementary and Alternative Medicine Open access 2020 303
3 In silico repositioning of approved drugs for rare and neglected diseases Sean Ekins, Antony John Williams, Matthew David Krasowski et al. · Drug Discovery Today Open access 7 Mar 2011 296
4 Web-scale distributional similarity and entity set expansion Patrick Pantel, Eric Crestan, Arkady Borkovsky et al. Conference paperOpen access 2009 278
5 Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication Johanna Lena Theruvath et al. · Nature Medicine Open access 13 Jan 2022 261
All 60 most cited papers, with filters and sorting

Which keywords describe research at Collaborative Drug Discovery (United States)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Glycemic Control, Insulin Therapy, Heart Failure, Clinical Guidelines, Depression, Cancer Immunotherapy, Treatment Guidelines and Deep Learning.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 29 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 29 words, with their numbers
  1. Deep Learning2▲ 1.80×16 topics
  2. Epidemiology2▲ 1.58×14 topics
  3. Glycemic Control2▲ 33×4 topics
  4. Insulin Therapy2▲ 35×3 topics
  5. Machine Learning2▲ 1.37×9 topics
  6. Depression2▲ 4.9×6 topics
  7. Healthcare2▲ 3.4×4 topics
  8. Clinical Guidelines1▲ 12×2 topics
  9. Education1▲ 2.2×4 topics
  10. Heart Failure1▲ 8.1×6 topics
  11. Quality of Life1▲ 2.6×4 topics
  12. Innovation1▲ 3.4×2 topics
  13. Cancer Immunotherapy1▲ 21×3 topics
  14. Management1▲ 4.0×3 topics
  15. Treatment Guidelines1▲ 15×2 topics
  16. Artificial Intelligence1▲ 2.1×5 topics
  17. Chemotherapy1▲ 4.2×7 topics
  18. Tumor Microenvironment1▲ 6.7×5 topics
  19. Virtual Reality1▲ 5.8×4 topics
  20. Avulsion1▲ 173×1 topic
  21. Biomedical Engineering1▲ 19×1 topic
  22. Cardiovascular Outcomes1▲ 46×1 topic
  23. Hackathons1▲ 76×1 topic
  24. History1▲ 3.8×1 topic
  25. Psychology1▲ 20×1 topic
  26. Science1▲ 11×2 topics
  27. Traumatic Dental Injuries1▲ 173×1 topic
  28. Type 2 Diabetes1▲ 12×1 topic
  29. User Experience1▲ 31×2 topics

Which research topics does Collaborative Drug Discovery (United States) publish most on?

By volume in 2022-now: Biomedical and Engineering Education, Academic and Historical Perspectives in Psychology, Diabetes Treatment and Management and Dental Trauma and Treatments.

Biomedical and Engineeri…1Biomedical and Engineering Education: 1 fractional worksAcademic and Historical …1Academic and Historical Perspectives in Psychology: 1 fractional worksDiabetes Treatment and Management: 1 fractional worksDental Trauma and Treatm…1Dental Trauma and Treatments: 1 fractional worksMonoclonal and Polyclona…1Monoclonal and Polyclonal Antibodies Research: 1 fractional worksCancer Immunotherapy and Biomarkers: 1 fractional worksCAR-T cell therapy research: 1 fractional worksInnovative Human-Technol…1Innovative Human-Technology Interaction: 1 fractional worksSoftware System Performance and Reliability: 1 fractional worksDigital Mental Health Interventions: 1 fractional works
Biomedical EngineeringGeneral PsychologyEndocrinology, Diabetes and MetabolismEmergency Medical Services5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Biomedical and Engineering Education Biomedical Engineering 1 works
  2. 2 Academic and Historical Perspectives in Psychology General Psychology 1 works
  3. 3 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 1 works
  4. 4 Dental Trauma and Treatments Emergency Medical Services 1 works
  5. 5 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  6. 6 Cancer Immunotherapy and Biomarkers Oncology 1 works
  7. 7 CAR-T cell therapy research Oncology 1 works
  8. 8 Innovative Human-Technology Interaction Human-Computer Interaction 1 works
  9. 9 Software System Performance and Reliability Computer Networks and Communications 1 works
  10. 10 Digital Mental Health Interventions Applied Psychology 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available33.3%not open66.7%

World: 40% of research is openly available.

with international co-authors17.4%domestic only82.6%

World: 18% is written across borders.

How has Collaborative Drug Discovery (United States)'s research output changed?

Output in 2022-2025 was 4% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Collaborative Drug Discovery (United States) as a percentage of every work published that year, 0.00012% in 2024.

still counting0.00025%0.00050%0.00075%Collaborative Drug Discovery (United States)0.00026% in 202519801990200020102020

Fractional works of Collaborative Drug Discovery (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Burlingame

All research institutions in Burlingame

Share Collaborative Drug Discovery (United States)'s ranking

Collaborative Drug Discovery (United States) on Science Explorer

A card with Collaborative Drug Discovery (United States)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Collaborative Drug Discovery (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.